Skip to content
healthcare.dev

ZYPREXA Zydis

NDC 61269-650, Olanzapine, tablet, orally disintegrating, from H2-Pharma LLC.

Product NDC
61269-650
Status
Listed
Labeler
H2-Pharma LLC
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021086
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61269-650 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLANZAPINE5 mg/1

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
61269-650-356126906503530 DOSE PACK in 1 CARTON (61269-650-35) / 1 BLISTER PACK in 1 DOSE PACK (61269-650-01) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b418946a-1ab4-4d89-a012-d94fc361a3c4

Use it

Look up 61269-650 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61269-650 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61269-650. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.